These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 8370193

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Quinapril in chronic heart failure.
    Northridge DB, Dargie HJ.
    Am J Hypertens; 1990 Nov; 3(11):283S-287S. PubMed ID: 2261147
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
    Northridge DB, Rose E, Raftery ED, Lahiri A, Elder AT, Shaw TR, Henderson E, Dargie HJ.
    Eur Heart J; 1993 Mar; 14(3):403-9. PubMed ID: 8458362
    [Abstract] [Full Text] [Related]

  • 6. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
    Nussberger J, Fleck E, Bahrmann H, Delius W, Schultheiss HP, Brunner HR.
    Eur Heart J; 1994 Dec; 15 Suppl D():113-22. PubMed ID: 7713100
    [Abstract] [Full Text] [Related]

  • 7. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL, Sorkin EM.
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [Abstract] [Full Text] [Related]

  • 8. The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure.
    Holt P, Najm J, Sowton E.
    Eur J Clin Pharmacol; 1986 Aug; 31(1):9-14. PubMed ID: 3023100
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ, Posvar E.
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
    Packer M, Lee WH, Medina N, Yushak M.
    J Am Coll Cardiol; 1985 Sep; 6(3):635-45. PubMed ID: 2993397
    [Abstract] [Full Text] [Related]

  • 14. Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm.
    Kromer EP, Elsner D, Riegger GA.
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):9-14. PubMed ID: 1696671
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
    Leier CV, Patrick TJ, Hermiller J, Pacht KD, Huss P, Magorien RD, Unverferth DV.
    Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.